Citation: Sh. Fatemi, Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly, MOL PSYCHI, 6(2), 2001, pp. 129-133
Authors:
Fatemi, SH
Earle, JA
Stary, JM
Lee, S
Sedgewick, J
Citation: Sh. Fatemi et al., Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia, NEUROREPORT, 12(15), 2001, pp. 3257-3262
Citation: Sh. Fatemi et Ar. Halt, Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism, SYNAPSE, 42(4), 2001, pp. 281-284
Citation: Sh. Fatemi et al., Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression, MOL PSYCHI, 5(6), 2000, pp. 654-663
Authors:
Fatemi, SH
Emamian, ES
Kist, D
Sidwell, RW
Nakajima, K
Akhter, P
Shier, A
Sheikh, S
Bailey, K
Citation: Sh. Fatemi et al., Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice, MOL PSYCHI, 4(2), 1999, pp. 145-154
Citation: Sh. Fatemi et al., Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression, ANN PHARMAC, 33(6), 1999, pp. 701-703